Efficacy and safety of risankizumab in patients with moderately to severely active Crohn's disease: interim results from the SEQUENCE open-label extension study
利沙珠单抗治疗中重度活动性克罗恩病患者的疗效和安全性:SEQUENCE开放标签扩展研究的中期结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjaf213
Peyrin-Biroulet, Laurent; Atreya, Raja; Danese, Silvio; Lindsay, James O; Chapman, J Casey; Anschutz, Toni; Huang, Xiu; Zambrano, Javier; van Haaren, Stijn; Joshi, Namita; Duan, W Rachel; Cross, Raymond K